Epitopea Announces License and Research Collaboration
MONTREAL and CAMBRIDGE, United Kingdom, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf...
MONTREAL and CAMBRIDGE, United Kingdom, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf...